Glenmark Takes On Remogliflozin Infringers In India

Alleged infringers of the patent on remogliflozin are facing legal heat in India from Glenmark, in an ongoing case where copies of the product were apparently offered for sale including via third-party trading sites.

Gavel
Glenmark Wards Off Infringers Of The Patent On Remogliflozin • Source: Shutterstock

Glenmark Pharmaceuticals Ltd. has moved decisively to fend off alleged attempts by certain local firms in India to infringe on the local patents for its licensed diabetes therapy remogliflozin etabonate, which has had strong run in the country since its launch earlier this year.

Mumbai-based Glenmark had earlier this year moved the Delhi High Court and secured a restraining order against some companies, believed...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from India

More from Focus On Asia